JPMorgan upgraded Cognex (CGNX) to Neutral from Underweight with an unchanged price target of $55. The firm says the company’s “rapid” margin improvement, cost initiatives, and expanding customer base warrant an upgrade to Neutral. Cognex’s execution and a strengthening macro backdrop justify a premium valuation for the shares, positioning the company for further upside as sector rotation favors innovation and operational leverage, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CGNX: